is commonly treated with anti-glaucoma medications. Recently, selective laser trabeculoplasty (SLT) has been demonstrated to lower the intraocular pressure (IOP) and medication use in NTG.

announces another groundbreaking milestone as the first practice in Texas to offer the Voyager Direct Selective Laser Trabeculoplasty (DSLT) system. This state-of-the-art technology represents a ...

The mean baseline IOP after washout of anti-glaucoma medication was 16.2 ± 2.2 mmHg. The central corneal thickness was 550 ± 36.9 micrometres. The mean SLT shots applied was 191.1 ± 26.3 per ...

patients randomized to selective laser trabeculoplasty (SLT) had a 29% lower rate of glaucoma progression versus eye drop ...